Taejeon, South Korea

Chi-Wang Yoon


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chi-Wang Yoon: A Visionary Inventor Shaping the Future of DNA Chip Technology

Introduction

Chi-Wang Yoon, a visionary inventor based in Taejeon, South Korea, is renowned for his passion for innovation and his relentless pursuit of excellence in the field of DNA chip technology. Yoon's groundbreaking work has solidified his reputation as a pioneering inventor whose impact will be felt for generations to come.

Latest Patents

With a total of 1 patent to his name, one of Chi-Wang Yoon's notable inventions is the "Method for preparing a DNA chip and use thereof." This innovative method involves cloning a probe with a linker coupled to an oligonucleotide, transforming host cells, culturing the cells to recover the probe, and integrating the double-helical probes on a slide. This patent also relates to a DNA chip for HPV diagnosis and a method for diagnosing the presence or genotype of HPV using the DNA chip.

Career Highlights

Chi-Wang Yoon is a key figure at Genomictree, Inc., where he continues to push the boundaries of DNA chip technology. His work at Genomictree has been instrumental in advancing the field and has earned him respect and admiration from his peers.

Collaborations

Yoon collaborates closely with colleagues such as Sung-Whan An and Tae-Jeong Oh, who share his dedication to innovation and excellence. Together, they form a formidable team driving forward cutting-edge research and development in the field of DNA chip technology.

Conclusion

In conclusion, Chi-Wang Yoon's passion for innovation, coupled with his unwavering commitment to excellence, sets him apart as a visionary inventor shaping the future of DNA chip technology. His groundbreaking inventions and collaborations are a testament to his enduring impact on the field, ensuring that his legacy will endure for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…